MILZA 50MG CAPSULE belongs to the group of medicines known as selective serotonin and norepinephrine reuptake inhibitors (SNRIs) indicated for the management of fibromyalgia. Fibromyalgia is a long-lasting condition that causes pain and tenderness throughout the body.
MILZA 50MG CAPSULE contains Milnacipran, which works by increasing the amount of natural substances, such as serotonin and norepinephrine, which help stop the movement of pain signals in the brain. Thereby, it helps manage fibromyalgia.
In some cases, MILZA 50MG CAPSULE may cause side effects such as nausea, vomiting, headache, constipation, dizziness, and dry mouth. Most of these side effects may not require medical attention and resolve gradually over time. However, you are advised to talk to the doctor if any of the side effects persist or worsen.
Consult the doctor if you are pregnant or breastfeeding. MILZA 50MG CAPSULE is not recommended for children as safety and effectiveness have not been established. Avoid consuming alcohol while on treatment with MILZA 50MG CAPSULE. Keep the doctor informed about your health condition and medications to rule out any interactions/side effects.